MYC promotes metabolic reprogramming in cancer and is involved in lipogenesis by pronouncedly activating acetyl-CoA carboxylase (ACACA), fatty acid synthetase (FASN), and stearoyl-CoA desaturase (SCD) (Zeller et al., 2003; Loven et al., 2012). The gene discussed is SCD; the disease is cancer.